SRS Ltd.

Analysts predict firm gold prices next week as investors await Federal Reserve cues and crucial inflation data. US dollar and economic reports will also influence bullion.

US imposes visa restrictions on owner of India-based pharmacy, KS International Traders, and 13 associates for fentanyl trafficking.

Amendments to Insolvency and Bankruptcy Code unlikely to uplift recovery rates for ARCs, lenders, but may improve predictions.

Report: Asset reconstruction companies (ARCs) cumulative recovery rate of security receipts (SRs) to reach 90% next fiscal year.

NFRA issues inspection reports for Price Waterhouse, BSR, SRBC, MSKA & Associates LLP, flagging audit shortcomings and compliance issues.

Ola Electric receives Rs 95.81 crore PLI-Auto incentive from Ministry of Heavy Industries, reinforcing its role in India's EV manufacturing and localization efforts.

Mahindra Group extends its Battery-as-a-Service (BaaS) model to its entire eSUV lineup, including SPORTEQ, XEV 9S, and XEV 9e, lowering upfront costs and boosting EV adoption.

The RBI announced a Rs 30,000 crore government securities buyback on Sept 3 via E-Kuber auction to manage surplus liquidity in the banking system.

Gold prices fall for the third consecutive day, dropping Rs 3,300, as a strong US dollar and profit-booking impact the market. Customs duty cut rumors also weigh.

Sebi's new proposal to exempt merchant bankers for Rs 10,000 bonds will boost small-value issuances, online platforms, and retail investor access to corporate debt.

The ED has frozen bank deposits worth Rs 51.75 crore in a fresh action related to the DHFL bank-loan fraud case, involving the Wadhawan family and a UK property.

Ola Electric receives Rs 95.81 crore PLI-Auto incentive from Ministry of Heavy Industries, reinforcing its role in India's EV manufacturing and localization efforts.

Mahindra Group extends its Battery-as-a-Service (BaaS) model to its entire eSUV lineup, including SPORTEQ, XEV 9S, and XEV 9e, lowering upfront costs and boosting EV adoption.

The RBI announced a Rs 30,000 crore government securities buyback on Sept 3 via E-Kuber auction to manage surplus liquidity in the banking system.

Maharashtra FDA cancels Cipla Pharma's Pune unit drug sale licenses due to serious irregularities in packaging, storage, and recall of Reactin Plus Tablets.